Zhongchao (NASDAQ:ZCMD – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday.
Separately, Weiss Ratings upgraded Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Check Out Our Latest Research Report on Zhongchao
Zhongchao Stock Down 19.1%
Key Zhongchao News
Here are the key news stories impacting Zhongchao this week:
- Positive Sentiment: Short interest in Zhongchao fell sharply in July, dropping 79.7% to 76,847 shares by July 15, which could reduce bearish pressure on the stock.
- Neutral Sentiment: Zhongchao was highlighted in a TipRanks article on penny stocks to watch, which may have increased trading interest but does not by itself change fundamentals. Article Title
- Neutral Sentiment: The stock experienced repeated LULD-related trading halts on July 23, signaling extreme volatility and heavy speculative trading rather than a specific operational development.
- Negative Sentiment: The company announced a registered direct offering of 4,545,455 Class A ordinary shares, or pre-funded warrants, at $1.10 per share, a move that may dilute shareholders and pressure the stock. Article Title
Zhongchao Company Profile
Zhongchao Inc provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand.
Further Reading
- Five stocks we like better than Zhongchao
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.
